JAMA Oncology Publication Demonstrates EndoPredict Significantly Outperforms Oncotype DX Genetics Investing
Kura Oncology Provides Update on Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer Biotech Investing
Evoke Announces Discovery of Sex-Based Pharmacokinetic Differences for Gimoti Pharmaceutical Investing
UroGen Pharma Strengthens Management Team with the Appointment of Stephen Mullennix as COO Pharmaceutical Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
